Pharmaceutics · 2021 · 23 citations · 28 references
PharmacyBiotechnologyMolecular BiologyDrug DeliveryGene DeliveryGene ExpressionGene Delivery VectorsMessenger Rna DeliveryMrna StabilityNucleic Acid DeliveryCytotoxicity AssaysLuciferase ReportersMessenger Rna (Mrna) ChemistryMrna DeliveryMrna Delivery SystemsProtein Expression LevelsRna Delivery SystemsSafety Profile Characterization
We previously found that a complex comprising plasmid DNA (pDNA), polyethylenimine (PEI), and γ-polyglutamic acid (γ-PGA) had high transgene efficiency without cytotoxicity in vitro and in vivo. However, messenger RNA (mRNA) remains an attractive alternative to pDNA. In this study, we developed a safe and effective delivery system for mRNA to prevent its degradation and efficiently deliver it into target cells. Various cationic and anionic complexes were produced containing PEI, γ-PGA, and an mRNA encoding firefly luciferase. Their physicochemical properties and cytotoxicities were analyzed and the in vitro and in vivo protein expression were determined. The cationic mRNA/PEI complex showed high in vitro protein expression with strong cytotoxicity. The anionic complex was constructed as mRNA/PEI8/γ-PGA12 complex with a theoretical charge ratio of 1:8:12 based on the phosphate groups of the mRNA, nitrogen groups of PEI, and carboxylate groups of γ-PGA. It was stable and showed high in vitro protein expression without cytotoxicity. After intravenous administration of mRNA/PEI8/γ-PGA12 complex to mice, high protein expression was observed in the spleen and liver and slight expression was observed in the lung over 24 h. Thus, the newly constructed mRNA/PEI8/γ-PGA12 complex provides a safe and effective strategy for the delivery of mRNA.
28
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy
S. Moein Moghimi, Peter Symonds, J. Clifford Murray et al. · Molecular Therapy · 2005 · 1.1K citations · Full text
Pharmacy, Pharmacology, Toxicology +17